http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019032536-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9def71d7d1416fefedce62edc5b5f15 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8499834023cba5c0eed739ab8f83b004 |
publicationDate | 2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2019032536-A1 |
titleOfInvention | ENHANCING MEDICATION USING HYDROGEN |
abstract | Embodiments of the present invention generally relate to medicinal compositions (e.g., compositions comprising an active pharmaceutical agent) such as those comprising liquid hydrogen and / or hydrogen gas. In some embodiments, the composition comprises hydrogen and / or noble gas (s) in a medicinal composition, for example, in the aqueous phase (e.g., dissolved). For example, in some cases, the medicinal composition may comprise an active pharmaceutical ingredient and hydrogen (¾) and / or noble gas (s). The noble gas may be, for example, xenon, argon or the like. In some embodiments, the hydrogen and / or the noble gas (s) may be infused with the composition (eg, such that at least a portion of the hydrogen gas and / or gas (s) noble (s) is dissolved in the composition). Examples of active pharmaceutical ingredients include cannabinoids, such as tetrahydrocannabinol (THC), cannabidiol (CBD), and the like. Such compositions may be useful, for example, for treating animal and human diseases, for improving athletic performance, for improving the overall health of a subject, or the like. Such compositions described herein may be administered (e.g., orally, intravenously, inhaled, etc.) to a subject. |
priorityDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.